EXHIBIT 32

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND

THE CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report of SensiVida Medical Technologies, Inc., (the “Company”) on Form 10-Q for the quarter ended August 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kamal Sarbadhikari, Chief Executive Officer of the Company, and I, Frank D. Benick, Chief Financial Officer of the Company, certify, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13 (a) of 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. §78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 20, 2009	/s/ Kamal Sarbadhikari
	Kamal Sarbadhikari
	Chief Executive Officer
October 20, 2009	/s/ Frank D. Benick
	Chief Financial Officer

The foregoing certification is being furnished in accordance with Securities and Exchange Commission Release Nos. 34-47551 and 34-47986 and shall not be considered “filed” as part of this 10-Q.

This certification is made solely for purposes of 18 U.S.C. Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.

25